New Grant Glues Together Research Experts to Tackle Incurable Diseases
An international grant to Thomas Kodadek, Ph.D., will advance his lab’s work on molecular glue degraders for incurable diseases.
Posts tagged as
Cancer
Mapping Hormone Signaling to Outsmart Cancer Resistance
Kendall Nettles, Ph.D., applies detailed 3-D views and computer models to reveal how hormones, the body’s chemical messengers, and their receptors work. The goal? To tackle real‑world medical problems, including cancer drug resistance. Nettles’ lab works to translate molecular-level discoveries into better, safer medicines. Exploring the…
High-Speed Science: Using Robotics to Tackle the Toughest Challenges in Medicine
Timothy Spicer, Ph.D., and Louis Scampavia, Ph.D., use robotics and biochemistry to unearth potential new medicines. When scientists discover something new about a disease, it presents an exciting opportunity to find a new treatment. But where to start? Discovering the needle in the haystack…
A Special Place to Address Rare Diseases
The Journey from Molecule to Medicine – A Photo Tour From molecules to medicines, every cure begins with understanding. At the Wertheim UF Scripps Institute, we unlock tomorrow’s therapies by understanding the complexity of life. “We can also apply this to areas of unmet need that maybe a pharmaceutical…
Every Cure Begins With Understanding
stopping DiSease by understanding its root cause…
Targeting Cells’ Master Regulator Opens a New Frontier in Cancer Prevention and Therapy
Donna Zhang, Ph.D., has dedicated her career to unraveling how cells’ defense system against oxidative stress, controlled by a gene called NRF2, can be strategically activated to prevent disease — or disarmed to help destroy cancer cells. Donna Zhang, Ph.D. The Big Picture What if…
Wertheim UF Scripps Institute Research Garners $15.7 Million in New Awards
"These grants highlight The Wertheim UF Scripps Institute’s unique expertise in areas that include neuroscience, immunology, biochemistry, drug discovery and RNA therapeutics,” said Scientific Director Patrick Griffin, Ph.D.
Outsmarting Cancer 2026
Outsmarting cancer 2026 See the Event Recap and Photo Gallery Thanks to all who attended Outsmarting Cancer 2026. See event photos at the link.
Antibody-Cancer Drug Combo Shows Promise Against Aggressive Lymphoma
A cancer-killing compound, called tiancimycin, combined with a cancer-seeking antibody, shows promise against an aggressive type of lymphoma.
Scientists Wipe Out Aggressive Brain Cancer Tumors by Targeting Cellular ‘Motors’
Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.
